Agnete Kirkeby

Agnete is an associate professor at the Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW) at University of Copenhagen (Denmark). Her group specialises in generating specific subtypes of human neurons from stem cells as transplantation therapy for brain diseases as well as for disease modelling. Agnete and collaborators have developed a stem cell-based dopamine cell product (STEM-PD), which is now in clinical trial for Parkinson’s Disease. Agnete and her group further works on the preclinical development of stem cell therapies for treatment of dementia symptoms in Parkinson’s Disease as well as on using stem cells for modelling Parkinson’s Disease, Alzheimer’s Disease, Schizopphrenia and appetite regulation in the dish for development of novel disease-modifying therapies.